WO2004100774A3 - Receptors and membrane-associated proteins - Google Patents

Receptors and membrane-associated proteins Download PDF

Info

Publication number
WO2004100774A3
WO2004100774A3 PCT/US2004/009524 US2004009524W WO2004100774A3 WO 2004100774 A3 WO2004100774 A3 WO 2004100774A3 US 2004009524 W US2004009524 W US 2004009524W WO 2004100774 A3 WO2004100774 A3 WO 2004100774A3
Authority
WO
WIPO (PCT)
Prior art keywords
membrane
remap
associated proteins
receptors
polynucleotides
Prior art date
Application number
PCT/US2004/009524
Other languages
French (fr)
Other versions
WO2004100774A2 (en
Inventor
Anita Swarnakar
Thomas W Richardson
David Chien
Jonathan T Wang
Pei Jin
Amy D Wilson
Shanya D Becha
Phillip R Hawkins
Narinder K Chawla
Kristin D Favero
Preeti G Lal
Y Tom Tang
Mariah R Baughn
Craig H Ison
Original Assignee
Incyte Corp
Anita Swarnakar
Thomas W Richardson
David Chien
Jonathan T Wang
Pei Jin
Amy D Wilson
Shanya D Becha
Phillip R Hawkins
Narinder K Chawla
Kristin D Favero
Preeti G Lal
Y Tom Tang
Mariah R Baughn
Craig H Ison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Anita Swarnakar, Thomas W Richardson, David Chien, Jonathan T Wang, Pei Jin, Amy D Wilson, Shanya D Becha, Phillip R Hawkins, Narinder K Chawla, Kristin D Favero, Preeti G Lal, Y Tom Tang, Mariah R Baughn, Craig H Ison filed Critical Incyte Corp
Publication of WO2004100774A2 publication Critical patent/WO2004100774A2/en
Publication of WO2004100774A3 publication Critical patent/WO2004100774A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
PCT/US2004/009524 2003-05-07 2004-03-25 Receptors and membrane-associated proteins WO2004100774A2 (en)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US46905503P 2003-05-07 2003-05-07
US60/469,055 2003-05-07
US47319303P 2003-05-23 2003-05-23
US47285703P 2003-05-23 2003-05-23
US60/472,857 2003-05-23
US60/473,193 2003-05-23
US47763503P 2003-06-10 2003-06-10
US60/477,635 2003-06-10
US48345203P 2003-06-26 2003-06-26
US60/483,452 2003-06-26
US49038403P 2003-07-24 2003-07-24
US60/490,384 2003-07-24
US52546303P 2003-11-26 2003-11-26
US60/525,463 2003-11-26
US52984003P 2003-12-15 2003-12-15
US60/529,840 2003-12-15

Publications (2)

Publication Number Publication Date
WO2004100774A2 WO2004100774A2 (en) 2004-11-25
WO2004100774A3 true WO2004100774A3 (en) 2007-08-16

Family

ID=33459465

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/009524 WO2004100774A2 (en) 2003-05-07 2004-03-25 Receptors and membrane-associated proteins

Country Status (1)

Country Link
WO (1) WO2004100774A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107862B2 (en) 2007-09-04 2015-08-18 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
US9428574B2 (en) 2011-06-30 2016-08-30 Compugen Ltd. Polypeptides and uses thereof for treatment of autoimmune disorders and infection

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013204943A1 (en) * 2007-09-04 2013-05-16 Compugen Ltd. Polypeptides and polynucleotides related to fxyd3, and uses thereof as a drug target for producing drugs and biologics
PT2190469E (en) * 2007-09-04 2015-06-25 Compugen Ltd Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
EP2389583A1 (en) * 2009-01-22 2011-11-30 Ludwig Institute for Cancer Research, Ltd. Methods and compositions for diagnosis and treatment of malignant and non-malignant gammopathies
CA2848985A1 (en) 2012-02-01 2013-08-08 Compugen Ltd. C10rf32 antibodies, and uses thereof for treatment of cancer
AU2019271304A1 (en) * 2018-05-15 2020-11-26 The Council Of The Queensland Institute Of Medical Research Modulating immune responses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061471A2 (en) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061471A2 (en) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107862B2 (en) 2007-09-04 2015-08-18 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
US9375466B2 (en) 2007-09-04 2016-06-28 Compugen Ltd Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
US9555087B2 (en) 2007-09-04 2017-01-31 Compugen Ltd Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
US9428574B2 (en) 2011-06-30 2016-08-30 Compugen Ltd. Polypeptides and uses thereof for treatment of autoimmune disorders and infection

Also Published As

Publication number Publication date
WO2004100774A2 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
WO2001098351A3 (en) G-protein coupled receptors
WO2003027228A3 (en) Receptors and membrane-associated proteins
WO2001057085A3 (en) G-protein coupled receptors
WO2003048305A3 (en) Receptors and membrane-associated proteins
WO2001087937A3 (en) G-protein coupled receptors
WO2001098323A8 (en) G-protein coupled receptors
WO2003070902A3 (en) Receptors and membrane-associated proteins
WO2002094990A3 (en) Receptors and membrane-associated proteins
WO2001072836A3 (en) G-protein coupled receptors
WO2004100774A3 (en) Receptors and membrane-associated proteins
WO2003068943A3 (en) Secreted proteins
WO2001090359A3 (en) G-protein coupled receptors
WO2002026825A3 (en) G-protein coupled receptors
WO2003025130A3 (en) Receptors and membrane-associated proteins
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2001066742A3 (en) G-protein coupled receptors
WO2002063004A3 (en) G-protein coupled receptors
WO2002057454A3 (en) Receptors and membrane-associated proteins
WO2003087300A3 (en) Secreted proteins
WO2004029218A3 (en) Receptors and membrane-associated proteins
WO2002063006A3 (en) Receptors and membrane-associated proteins
WO2004044159A3 (en) Receptors and membrane-associated proteins
WO2004094589A3 (en) Secreted proteins
WO2002079448A3 (en) G-protein coupled receptors
WO2004022705A3 (en) Neurotransmission-associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: COMMUNICATION PURSUANT TO RULE 69(1) EPC (EPO FORM 1205A) SENT 26-01-2006.

122 Ep: pct application non-entry in european phase